NUCKS1 and breast carcinoma: In breast carcinoma, NUCKS1 has exhibited higher expression than other investigated markers (including Ki67, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and cytokeratin 5/6) [40, 41].